A novel hydrogel scaffold for the prevention or reduction of the recurrence of keloid scars postsurgical excision - 23/10/13
Supported by Halscion Inc, Suwanee, Georgia. |
|
Disclosure: Dr Berman has served as a consultant for GSK, Excaliard, Pfizer, and Halscion; an adviser for Pfizer and Halscion; and an investigator for Halscion. Dr Garikaparthi has served as an investigator for Halscion. Drs Smith and Newburger have no conflicts of interest to declare. |
|
Preliminary data were presented at the American Academy of Dermatology Annual Meeting in San Diego, California, on March 16, 2012. |
Vol 69 - N° 5
P. 828-830 - novembre 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?